Skip to main content Accessibility help
×
Home

An Outbreak of Hospital-Acquired Hepatitis B Virus Infection Among Patients Receiving Chronic Hemodialysis

  • Yvan J.E Hutin (a1) (a2), Susan T. Goldstein (a1), Jay K. Varma (a3), Joan B. O'Dair (a4), Eric E. Mast (a1), Craig N. Shapiro (a1) and Miriam J. Alter (a1)...

Abstract

Objective:

To investigate a cluster of hepatitis B virus (HBV) infections between December 1995 and May 1996 among chronic hemodialysis patients in one county.

Setting:

Two dialysis centers (A and B) and a hospital (C) in one county.

Patients:

Six case-patients who were dialyzed in one of two centers, A and B, and had all been hospitalized between January and February 1996 at hospital C.

Methods:

Patient 1, usually dialyzed in center A sero-converted to hepatitis B surface antigen (HBsAg) in December 1995 and could have been the source of infection for the others, who seroconverted between March and April 1996. Two cohort studies were conducted: one among patients dialyzed in center A to determine where transmission had occurred, and one among patients dialyzed at hospital C at the time patient 1 was hospitalized, to identify factors associated with infection.

Results:

Four (15%) of the 26 susceptible patients dialyzed at center A became infected with HBV. Hospitalization at hospital C when patient 1 was hospitalized was associated with infection (P=.002). A cohort study of the 10 susceptible patients dialyzed at hospital C during the time patient 1 was hospitalized did not identify specific risk factors for infection. However, supplies and multidose vials were shared routinely among patients, providing opportunities for transmission.

Conclusion:

When chronic hemodialysis patients require dialysis while hospitalized, their HBsAg status should be reviewed, and no instrument, supplies, or medications should be shared among them.

Copyright

Corresponding author

Centers for Disease Control and Prevention, MS G37, 1600 Clifton Rd, Atlanta, GA 30333

References

Hide All
1. Centers for Disease Control. Hepatitis Surveillance. Report no. 41. Atlanta, GA: CDC; 1977:1220.
2. Tokars, JI, Alter, MJ, Miller, E, Moyer, LA, Favero, MS. National surveillance of dialysis associated diseases in the United States—1994. ASAIO J 1997:43:108119.
3. Favero, MS, Alter, MJ. The reemergence of hepatitis B virus infection in hemodialysis centers. Seminars in Dialysis 1996;9:373374.
4. Hoofnagle, JH, Seeff, LB, Buskell Bales, Z, Gerety, RJ, Tabor, E. Serologic response in HB. In: Vyas, GN, Cohen, SN, Schmid, R, eds. Viral Hepatitis. A Contemporary Assessment of Etiology, Epidemiology Pathogenesis and Prevention. Philadelphia, PA: The Franklin Institute Press; 1978.
5. Centers for Disease Control and Prevention. Outbreaks of hepatitis B virus infection among hemodialysis patients—California, Nebraska, and Texas. MMWR 1996;45:285289.
6. Garner, JS, the Hospital Infection Control Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:5380.
7. Alter, MJ, Ahtone, J, Maynard, JE. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann Intern Med 1983;99:330333.
8. Carl, M, Francis, D. Maynard, JE. A common-source outbreak of hepatitis B in a hemodialysis unit. Dialysis and Transplantation 1983;12:222229.
9. Bond, WW, Favero, MS, Petersen, NJ, Gravelle, CR, Ebert, JW, Maynard, JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981;1:550551.
10. Crosnier, J, Jungers, P, Courouce, AM, Laplanche, A, Benhamou, E, Degos, F, et al. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II, haemodialysis patients. Lancet 1981;1:797800.
11. Stevens, CE, Alter, HJ, Taylor, PE, Zang, EA, Harley, EJ, Szmuness, W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984;311:496501.
12. Alter, MJ, Favero, MS, Francis, DP. Cost benefit of vaccination for hepatitis B in hemodialysis centers. J Infect Dis 1983;148:770771.
13. Centers for Disease Control. Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR 1982;31:317-322, 327,328.

An Outbreak of Hospital-Acquired Hepatitis B Virus Infection Among Patients Receiving Chronic Hemodialysis

  • Yvan J.E Hutin (a1) (a2), Susan T. Goldstein (a1), Jay K. Varma (a3), Joan B. O'Dair (a4), Eric E. Mast (a1), Craig N. Shapiro (a1) and Miriam J. Alter (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed